Seasonal flu epidemic in the Netherlands The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.
Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
Nature Nanotechnology publishes RIVM research on plastics On Thursday 20 January, Nature Nanotechnology published the article Quantitative tracing of uptake and transport of submicrometre plastics in crop plants using lanthanide chelates as a dual-functional tracer.
RIVM to play greater role in tuberculosis control The Committee for Practical Tuberculosis Control (CPT) will be transferred per 1 January 2022 to the National Institute for Public Health and the Environment (RIVM) after a period of 70 years with KNCV Tuberculosis Foundation.
Zoonoses Report 2020 focuses on emerging zoonoses The COVID-19 pandemic and the outbreak of the West Nile Virus in 2020 show that so-called emerging zoonoses pose a risk to the Netherlands. ANP
Awareness and use of cigarillos, heated tobacco and nicotine pouches relatively low The awareness and use of cigarillos, heated tobacco and nicotine pouches is relatively low. This is apparent from research by RIVM among Dutch people aged 13 and older, commissioned by the Ministry of Health, Welfare and Sport.
European project COHESIVE develops sustainable One Health approaches Today, fellow scientists and policymakers join the end symposium of the international project COHESIVE: One Health Structures in Europe.
RIVM recommends limiting number of e-cigarettes flavourings to 23 with tobacco taste only The government wishes to make e-cigarettes less attractive, in particular for young people.
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons